Autoimmune hemolytic anemia and common variable immunodeficiency: A case-control study of 18 patients

Medicine

Volumn 87, Issue 3, 2008, Pages 177-184

  Sève, Pascal ^a,b   Bourdillon, Laure ^a,b   Sarrot Reynauld, Francoise ^c   Ruivard, Marc ^d   Jaussaud, Rolland ^e   Bouhour, Damien ^f   Bonotte, Bernard ^g   Gardembas, Martine ^h   Poindron, Vincent ⁱ   Thiercelin, Marie France ^j   Broussolle, Christiane ^a,b   Oksenhendler, Eric ^k  

^a HÔTEL DIEU   (France)

^b UNIVERSITÉ LYON 1   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

^d UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^e REIMS UNIVERSITY HOSPITAL   (France)

^f Department of Infectious Diseases   (France)

^g DIJON UNIVERSITY HOSPITAL   (France)

^h ANGERS UNIVERSITY HOSPITAL   (France)

ⁱ UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^j CHU PURPAN   (France)

^k SAINT LOUIS HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DANAZOL; HEMOGLOBIN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; BONE MARROW TOXICITY; CANDIDIASIS; CHILD; CLINICAL ARTICLE; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG MEGADOSE; DRUG WITHDRAWAL; ENCEPHALITIS; ENTEROBACTER INFECTION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INFECTION; LYMPHOMA; MALE; PHENOTYPE; PNEUMOCYSTIS PNEUMONIA; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; REMISSION; SEPTICEMIA; SPLENECTOMY; THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANEMIA, HEMOLYTIC, AUTOIMMUNE; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COMMON VARIABLE IMMUNODEFICIENCY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MIDDLE AGED; SPLENECTOMY;

EID: 44449119824     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/MD.0b013e31817a90ba     Document Type: Article

References (33)

1. Arnold DM, Dentali F, Crowther MA, Meyer RM, Cook RJ, Sigouin C, Fraser GA, Lim W, Kelton JG. Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. Ann Intern Med. 2007;146:25-33.
2. Brandt D, Gershwin ME. Common variable immune deficiency and autoimmunity. Autoimmun Rev. 2006;5:465-470.
3. Calabrese LH, Molloy ES, Huang D, Ransohoff RM. Progressive multifocal leukoencephalopathy in rheumatic diseases: evolving clinical and pathologic patterns of disease. Arthritis Rheum. 2007;56:2116-2128.
4. Carbone J, Escudero A, Mayayo M, Ballesteros M, Perez-Corral A, Sanchez-Ramon S, Sarmiento E, Micheloud D, Fernandez-Cruz E. Partial response to anti-CD20 monoclonal antibody treatment of severe immune thrombocytopenic purpura in a patient with common variable immunodeficiency. Ann N Y Acad Sci. 2005;1051:666-671.
5. Cunningham-Rundles C. Hematologic complications of primary immune deficiencies. Blood Rev. 2002;16:61-64.
6. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999;92:34-48.
7. Dacie SJ. The immune haemolytic anaemias: a century of exciting progress in understanding. Br J Haematol. 2001;114:770-785.
8. El-Shanawany TM, Williams PE, Jolles S. Response of refractory immune thrombocytopenic purpura in a patient with common variable immunodeficiency to treatment with rituximab. J Clin Pathol. 2007;60:715-716.
9. Fellermann K, Stange EF. Chronic hepatitis C, common variable immunodeficiency and autoimmune hemolytic anemia. Coincidence by chance or common etiology? Hepatogastroenterology. 2000;47:1422-1424.
10. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, Blanchette VS, Bussel JB, Cines DB, Kelton JG, Lichtin AE, McMillan R, Okerbloom JA, Regan DH, Warrier I. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996;88:3-40.
11. Hermaszewski RA, Webster AD. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med. 1993;86:31-42.
12. Kim JJ, Thrasher AJ, Jones AM, Davies EG, Cale CM. Rituximab for the treatment of autoimmune cytopenias in children with immune deficiency. Br J Haematol. 2007;138:94-96.
13. Kokron CM, Errante PR, Barros MT, Baracho GV, Camargo MM, Kalil J, Rizzo LV. Clinical and laboratory aspects of common variable immunodeficiency. An Acad Bras Cienc. 2004;76:707-726.
14. Leickly FE, Buckley RH. Successful treatment of autoimmune hemolytic anemia in common variable immunodeficiency with high-dose intravenous gamma globulin. Am J Med. 1987;82:159-162.
15. Mahevas M, Le Page L, Salle V, Cevallos R, Smail A, Duhaut P, Ducroix JP. Efficiency of rituximab in the treatment of autoimmune thrombocytopenic purpura associated with common variable immunodeficiency. Am J Hematol. 2006;81:645-646.
16. Michel M, Chanet V, Galicier L, Ruivard M, Levy Y, Hermine O, Oksenhendler E, Schaeffer A, Bierling P, Godeau B. Autoimmune thrombocytopenic purpura and common variable immunodeficiency: analysis of 21 cases and review of the literature. Medicine (Baltimore). 2004;83:254-263.
17. Oksenhendler E, Gerard L, Fieschi C, Malphettes M, Mouillot G, Jaussaud R, Viallard J, Gardembas M, Galicier L, Schleinitz N, Suarez F, Soulas-Sprauel P, Hachulla E, Jaccard A, Gardeur A, Theodorou I, Rabian C, Debre P. Infections in 252 patients with common variable immudeficiency. Clin Infect Dis. 2008 (in press).
18. Packman CH. Hemolytic anemia due to warm autoantibodies. Blood Rev. 2008;22:17-31.
19. Pavic M, Seve P, Malcus C, Sarrot-Reynault F, Peyramond D, Debourdeau P, Andriamanantena D, Bouhour D, Philippe N, Rousset H, Broussolle C. [Common variable immunodeficiency with autoimmune manifestations: study of nine cases; interest of a peripheral B-cell compartment analysis in seven patients]. Rev Med Interne. 2005;26:95-102.
20. Petz LD. Treatment of autoimmune hemolytic anemias. Curr Opin Hematol. 2001;8:411-416.
21. Piqueras B, Lavenu-Bombled C, Galicier L, Bergeron-van der Cruyssen F, Mouthon L, Chevret S, Debre P, Schmitt C, Oksenhendler E. Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol. 2003;23:385-400.
22. Quinti I, Soresina A, Spadaro G, Martino S, Donnanno S, Agostini C, Claudio P, Franco D, Maria Pesce A, Borghese F, Guerra A, Rondelli R, Plebani A. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol. 2007;27:308-316.
23. Rosen FS, Cooper MD, Wedgwood RJ. The primary immunodeficiencies. N Engl J Med. 1995;333:431-440.
24. Sanal O, Ersoy F, Metin A, Tezcan I, Berkel AI, Yel L. Selective IgA deficiency with unusual features: development of common variable immunodeficiency, Sjogren's syndrome, autoimmune hemolytic anemia and immune thrombocytopenic purpura. Acta Paediatr Jpn. 1995;37:526-529.
25. Sicherer SH, Winkelstein JA. Primary immunodeficiency diseases in adults. JAMA. 1998;279:58-61.
26. Sneller MC. Common variable immunodeficiency. Am J Med Sci. 2001;321:42-48.
27. Sneller MC, Strober W, Eisenstein E, Jaffe JS, Cunningham-Rundles C. NIH conference. New insights into common variable immunodeficiency. Ann Intern Med. 1993;118:720-730.
28. Strober W, Chua K. Common variable immunodeficiency. Clin Rev Allergy Immunol. 2000;19:157-181.
29. Wakim M, Shah A, Arndt PA, Garratty G, Weinberg K, Hofstra T, Church J. Successful anti-CD20 monoclonal antibody treatment of severe autoimmune hemolytic anemia due to warm reactive IgM autoantibody in a child with common variable immunodeficiency. Am J Hematol. 2004;76:152-155.
30. Wang J, Cunningham-Rundles C. Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID). J Autoimmun. 2005;25:57-62.
31. Wang J, Rodriguez-Davalos M, Levi G, Sauter B, Gondolesi GE, Cunningham-Rundles C. Common variable immunodeficiency presenting with a large abdominal mass. J Allergy Clin Immunol. 2005;115:1318-1320.
32. Warnatz K, Peter HH. [Classification and diagnosis of immunodeficiency syndromes]. Internist (Berl). 2004;45:868-881.
33. Wehr C, Kivioja T, Schmitt C, Ferry B, Witte T, Eren E, Vlkova M, Hernandez M, Detkova D, Bos PR, Poerksen G, von Bernuth H, Baumann U, Goldacker S, Gutenberger S, Schlesier M, Bergeron-van der Cruyssen F, Le Garff M, Debre P, Jacobs R, Jones J, Bateman E, Litzman J, van Hagen PM, Plebani A, Schmidt RE, Thon V, Quinti I, Espanol T, Webster AD, Chapel H, Vihinen M, Oksenhendler E, Peter HH, Warnatz K. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood. 2008;111:77-85.